Australian Antimicrobial Resistance Network - AAMRNet

In September 2020, MTPConnect announced the formation of an Australian-first network bringing together key stakeholders to address the impact of antimicrobial resistance (AMR) on human health.

The Australian Antimicrobial Resistance network - AAMRNet – has been established following recommendations in a new report, ‘Fighting Superbugs: A Report on the Inaugural Meeting of Australia’s Antimicrobial Resistance Stakeholders’, also released by MTPConnect and prepared in partnership with Biointelect.

Antimicrobial resistance occurs when microbes such as bacteria become resistant to drugs which once killed them, evolving to become untreatable ‘superbugs’.

Website: AAMRNet  |  Join AAMRNet, by contacting MTPConnect  |  Twitter: @AAMRNet_

Outcomes: The project now has 15 consortium, has presented to the parliamentary inquiry into approval processes for new drugs and medical technologies in Australia. AAMRNet is working on an AMR accelerator as well as a report to estimate the real human health impacts of AMR in Australia.

Consortium

State: Victoria

Consortium lead: MTPConnect

Industry contributions by: Pfizer ANZ, CSIRO, MSD Australia, GSK Australia, Botanix Pharmaceuticals, Recce Pharmaceuticals, SpeeDx, Biointelect, Monash Centre to Impact AMR, and Medicines Australia

MTPConnect grant: $469,367

Industry contributions: $781,000

Project duration: Ongoing

Additional partners of the AAMRNet include: DMTC, GARDP, AusBiotech, Roche Diagnostics Australia, Menzies School of Health Research, Formulytica, Epichem, BiomeBank, CO-ADD, Monash Biomedicine Discovery Institute and RESULTS International Australia.

Podcasts

• Launching Australia’s first Antimicrobial Resistance Network & the Fighting Superbugs report 
• Tackling a Global Health Challenge in Antimicrobial Resistance
• Australia’s Position to Tackle Antimicrobial Resistance
• World Antimicrobial Awareness Week 2020:
  • OUTBREAK Report On Superbugs
• World Antimicrobial Awareness Week 2021:
  • CO-ADD Sparks Up the Hunt for New Antibiotics
    
  • LBT Innovations’ Technology Aims to Speed Up Detection of Antimicrobial Resistance
  • Recce Scouts New Synthetic Anti-Infectives to Overcome Resistance
  • BiomeBank Develops Pioneering Microbiome Treatments

Videos

On the final day of World Antimicrobial Awareness Week 2021 (WAAW) the AMRelay 2021 took place - a 24 hour virtual and global event organised by the AMR Insights Ambassador Network - offering a series of consecutive contributions from stakeholders in the AMR sector. AAMRNet Co-Chair Andrew Bowskill presented an update on Australia’s first industry led, multi-stakeholder Antimicrobial Resistance Network, established and operated by MTPConnect to support actions to combat AMR in Australia. Watch the video below: